Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...
A K927 million health post under construction in Traditional Authority Kilupula (T/A) in Karonga District has sparked ...
Studienergebnisse DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies 23.12.2025 / 14:36 CET/CEST ...
News » DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results